Aureka Opens Its Drug Discovery Model as AI Biotech Moves Toward Lab-Linked Systems

Founder and CEO Dr. Weian Zhao is putting OpenDDE in public view while Aureka keeps its wet-lab data flywheel proprietary.

By · Published

Illustration of Aureka's OpenDDE showing a microscope and DNA helix connected by data pathways and nearby lab equipment

Founder and CEO Dr. Weian Zhao is putting OpenDDE in public view while Aureka keeps its wet-lab data flywheel proprietary.